Europos Sąjunga -
suomių -
EMA (European Medicines Agency)
pirfenidone axunio (previously pirfenidone aet)
axunio pharma gmbh - pirfenidone - idiopaattinen keuhkofibroosi - immunosuppressantit - pirfenidone aet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).
Europos Sąjunga -
suomių -
EMA (European Medicines Agency)
pirfenidone viatris
viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunosuppressantit - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).
Suomija -
suomių -
Fimea (Suomen lääkevirasto)
sorafenib sandoz 200 mg tabletti, kalvopäällysteinen
sandoz a/s - sorafenib tosilate - tabletti, kalvopäällysteinen - 200 mg - sorafenibi
Suomija -
suomių -
Fimea (Suomen lääkevirasto)
sorafenib mylan 200 mg tabletti, kalvopäällysteinen
mylan ab - sorafenib tosilate - tabletti, kalvopäällysteinen - 200 mg - sorafenibi
Europos Sąjunga -
suomių -
EMA (European Medicines Agency)
sorafenib accord
accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - antineoplastiset aineet - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.
Europos Sąjunga -
suomių -
EMA (European Medicines Agency)
silodosin recordati
recordati ireland ltd - silodosiinilla - prostatic hyperplasia - urologicals, alfa-salpaajat - hoitoon oireiden ja eturauhasen hyvänlaatuisen liikakasvun (bph) hoitoon aikuisilla miehillä.